YARROW BIOSCIENCE, INC. Basic Shares Outstanding (Weighted Average)
YARROW BIOSCIENCE, INC. (YARW) reported Basic Shares Outstanding (Weighted Average) of 858.00 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 858.00K shares, a 0.35% increase year-over-year.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 42.77K shares, a 0.22% increase year-over-year.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 855.00K shares, a 97.99% decline year-over-year.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 42.67K shares, a 99.90% decline year-over-year.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 10.27M shares, a 222.44% increase from fiscal 2022.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 3.19M shares, a 11.44% increase from fiscal 2021.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 2.86M shares, a 91.18% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. weighted average number of shares outstanding, basic for fiscal 2020 was 32.42M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 858.00K shares 10-Q · filed 2026-08-13 | 858.00K shares 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | 42.77K shares S-4/A · filed 2026-06-03 | 42.77M shares 10-Q · filed 2026-05-15 | ||||||
| 2025-12-31 | 42.77M shares S-4/A · filed 2026-06-03 | |||||||
| 2025-06-30 | 855.00K shares 10-Q · filed 2026-08-13 | 42.76M shares 10-Q · filed 2025-08-14 | 854.00K shares 10-Q · filed 2026-08-13 | 42.72M shares 10-Q · filed 2025-08-14 | 14.49M shares derived: average of 3 quarters · filed 2026-08-13 | 21.52M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | 42.67K shares S-4/A · filed 2026-06-03 | 42.67M shares 10-Q · filed 2025-05-08 | 21.31M shares derived: average of 2 quarters · filed 2026-06-03 | 28.40M shares derived: average of 3 quarters · filed 2026-06-03 | 31.95M shares derived: average of 4 quarters · filed 2026-06-03 | |||
| 2024-12-31 | 42.58M shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-06-03 | 42.58M shares derived: average of 2 quarters · filed 2026-06-03 | 42.58M shares derived: average of 3 quarters · filed 2026-06-03 | 42.59M shares S-4/A · filed 2026-06-03 | ||||
| 2024-09-30 | 42.59M shares 10-Q · filed 2024-11-07 | 42.59M shares derived: average of 2 quarters · filed 2025-08-14 | 42.59M shares 10-Q · filed 2024-11-07 | 39.76M shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2024-06-30 | 42.59M shares 10-Q · filed 2025-08-14 | 42.58M shares 10-Q · filed 2025-08-14 | 38.82M shares derived: average of 3 quarters · filed 2025-08-14 | 29.93M shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | 42.58M shares 10-Q · filed 2025-05-08 | 36.93M shares derived: average of 2 quarters · filed 2025-05-08 | 25.71M shares derived: average of 3 quarters · filed 2025-05-08 | 20.10M shares derived: average of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | 31.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 17.28M shares derived: average of 2 quarters · filed 2025-03-06 | 12.61M shares derived: average of 3 quarters · filed 2025-03-06 | 10.27M shares 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | 3.28M shares 10-Q · filed 2024-11-07 | 3.28M shares derived: average of 2 quarters · filed 2024-11-07 | 3.27M shares 10-Q · filed 2024-11-07 | 3.26M shares derived: average of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | 3.27M shares 10-Q · filed 2024-08-14 | 3.27M shares 10-Q · filed 2024-08-14 | 3.25M shares derived: average of 3 quarters · filed 2024-08-14 | 3.24M shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 3.25M shares 10-Q · filed 2024-05-09 | 3.24M shares derived: average of 2 quarters · filed 2024-05-09 | 3.23M shares derived: average of 3 quarters · filed 2024-05-09 | 3.23M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 3.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | 3.22M shares derived: average of 2 quarters · filed 2024-03-01 | 3.22M shares derived: average of 3 quarters · filed 2024-03-01 | 3.19M shares 10-K · filed 2024-03-01 | ||||
| 2022-09-30 | 3.22M shares 10-Q · filed 2023-11-13 | 57.93M shares 10-Q · filed 2022-11-14 | 3.22M shares derived: average of 2 quarters · filed 2023-11-13 | 3.17M shares 10-Q · filed 2023-11-13 | 57.12M shares 10-Q · filed 2022-11-14 | -32.84M shares derived: average of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | 3.22M shares 10-Q · filed 2023-08-14 | 57.93M shares 10-Q · filed 2022-08-12 | 3.15M shares 10-Q · filed 2023-08-14 | 56.66M shares 10-Q · filed 2022-08-12 | -44.87M shares derived: average of 3 quarters · filed 2023-08-14 | -20.64M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 3.08M shares 10-Q · filed 2023-05-11 | 55.39M shares 10-Q · filed 2022-05-12 | -68.91M shares derived: average of 2 quarters · filed 2023-05-11 | -28.60M shares derived: average of 3 quarters · filed 2023-05-11 | -8.59M shares derived: average of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -140.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -44.43M shares derived: average of 2 quarters · filed 2023-03-14 | -12.48M shares derived: average of 3 quarters · filed 2023-03-14 | 2.86M shares 10-K · filed 2023-03-14 | 51.47M shares 10-K · filed 2022-03-17 | |||
| 2021-09-30 | 52.03M shares 10-Q · filed 2022-11-14 | 51.72M shares derived: average of 2 quarters · filed 2022-11-14 | 50.78M shares 10-Q · filed 2022-11-14 | 48.65M shares derived: average of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | 51.41M shares 10-Q · filed 2022-08-12 | 50.16M shares 10-Q · filed 2022-08-12 | 47.52M shares derived: average of 3 quarters · filed 2022-08-12 | 46.12M shares derived: average of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | 48.87M shares 10-Q · filed 2022-05-12 | 45.57M shares derived: average of 2 quarters · filed 2022-05-12 | 44.36M shares derived: average of 3 quarters · filed 2022-05-12 | 41.94M shares derived: average of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | 42.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 42.10M shares derived: average of 2 quarters · filed 2022-03-17 | 39.62M shares derived: average of 3 quarters · filed 2022-03-17 | 32.42M shares 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | 41.93M shares 10-Q · filed 2021-11-10 | 38.30M shares derived: average of 2 quarters · filed 2021-11-10 | 29.13M shares 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | 34.66M shares 10-Q · filed 2021-08-12 | 22.66M shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |